Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced

B Liu1, M Fang, Y Lu

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, TX 77030, USA.

Oncogene
|April 21, 2001
PubMed

Insights

Basic fibroblast growth factor (bFGF) and insulin-like growth factor-1 (IGF-1) differentially regulate apoptosis in colon cancer cells. bFGF sustained protection via the MAPK pathway, while IGF-1 offered temporary protection through PI-3K/Akt.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • DiFi human colon carcinoma cells utilize a transforming growth factor-alpha (TGF-alpha)/epidermal growth factor (EGF) receptor autocrine loop.
  • Monoclonal antibody (mAb) 225 blocks EGF receptor activation, inducing G1 arrest and apoptosis in DiFi cells.

Purpose of the Study:

  • Investigate how basic fibroblast growth factor (bFGF) and insulin-like growth factor-1 (IGF-1) influence mAb 225-induced G1 arrest and apoptosis.
  • Elucidate the specific signaling pathways modulated by bFGF and IGF-1 in this context.

Main Methods:

  • Treatment of DiFi cells with mAb 225, bFGF, and IGF-1.
  • Assessment of cell cycle arrest (G1), apoptosis, and activation of signaling pathways (MAPK, PI-3K/Akt).
  • Utilized pathway-specific inhibitors (PD98059 for MEK/MAPK, LY294002 for PI-3K).

Main Results:

  • Both bFGF and IGF-1 activated the MEK/MAPK pathway; IGF-1 also activated PI-3K/Akt.
  • Both growth factors inhibited mAb 225-induced apoptosis, with bFGF providing sustained protection and IGF-1 temporary protection.
  • bFGF reversed mAb 225-induced G1 arrest markers (p27 Kip1, CDK-2 activity, Rb dephosphorylation), while IGF-1 did not.
  • bFGF's protective effects were MEK/MAPK-dependent, whereas IGF-1's were PI-3K-dependent.

Conclusions:

  • bFGF and IGF-1 differentially modulate apoptosis and cell cycle arrest induced by EGF receptor blockade in colon cancer cells.
  • The MEK/MAPK pathway mediates bFGF's sustained anti-apoptotic and cell cycle-regulating effects.
  • The PI-3K/Akt pathway mediates IGF-1's temporary anti-apoptotic effects.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.